Zentalis shareholders elect Blackwell and Kariuki as directors; say-on-pay passes with 59% support

Zentalis Pharmaceuticals, Inc.

Kimberly Blackwell received 48,055,584 votes for (78.9%) and Enoch Kariuki 45,008,378 for (73.9%) to Class I director seats.
Ratification of Ernst & Young as auditor for FY2024 passed nearly unanimously: 66,098,083 for, 5,665 against.
Advisory say-on-pay resolution approved with 36,128,130 for (59.3%) and 24,729,730 against (40.6%).
Total shares voted at annual meeting: 66,107,445, representing 93.09% of outstanding common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.